Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults
- 1 April 2005
- Vol. 23 (20) , 2591-2601
- https://doi.org/10.1016/j.vaccine.2004.11.034
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Hepatitis C virus dynamics and pathology: the role of CTL and antibody responsesJournal of General Virology, 2003
- 2nd meeting on novel adjuvants currently in/close to human clinical testing: World Health Organization—Organization Mondiale de la Santé Fondation Mérieux, Annecy, France, 5–7 June 2000Vaccine, 2002
- Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytesNature, 2002
- Polyvalent Envelope Glycoprotein Vaccine Elicits a Broader Neutralizing Antibody Response but Is Unable To Provide Sterilizing Protection against Heterologous Simian/Human Immunodeficiency Virus Infection in Pigtailed MacaquesJournal of Virology, 2001
- Cellular and Humoral Immune Responses to a Canarypox Vaccine Containing Human Immunodeficiency Virus Type 1 Env, Gag, and Pro in Combination with RGP120The Journal of Infectious Diseases, 2001
- Adjuvants—a classification and review of their modes of actionPublished by Elsevier ,1998
- Increased Anti-Influenza A Virus Cytotoxic T Cell Activity following Vaccination of the Chronically III Elderly with Live Attenuated or Inactivated Influenza Virus VaccineThe Journal of Infectious Diseases, 1995
- T Cell Responses to Pre-Erythrocytic Stages of Malaria: Role in Protection and Vaccine Development Against Pre-Erythrocytic StagesAnnual Review of Immunology, 1993
- Genetic immunization is a simple method for eliciting an immune responseNature, 1992
- Characterization of a Nontoxic Monophosphoryl Lipid AClinical Infectious Diseases, 1987